Surrozen financials
$31.98+7.89%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 |
|---|---|---|---|---|---|
| Revenue | $3.5M | $10.7M | $0.00 | $12.5M | $0.00 |
| Gross profit | $3.5M | $10.7M | $0.00 | $12.5M | $0.00 |
| Gross margin | 100.0% | 100.0% | — | 100.0% | — |
| Operating income | -$42.1M | -$25.5M | -$45.8M | -$44.3M | -$54.4M |
| Net income | -$242.0M | -$63.6M | -$43.0M | -$36.0M | -$54.6M |
| Net margin | −6960.8% | −596.6% | — | −288.0% | — |
| Diluted EPS | $-32.37 | $-21.67 | $-21.33 | $-15.56 | $-33.15 |
| EBITDA | -$41.6M | -$24.1M | -$41.1M | -$42.4M | -$52.2M |
| Operating cash flow | -$30.2M | -$17.6M | -$40.4M | -$44.1M | -$48.8M |
| Free cash flow | -$30.4M | -$17.7M | -$40.8M | -$44.9M | -$50.1M |
| Diluted shares | 7.5M | 2.9M | 2.0M | 2.3M | 1.6M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Cash & equivalents | $89.2M | $34.6M | $36.0M | $24.7M | $33.1M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $51.1M | $68.8M |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $98.7M | $48.5M | $46.1M | $89.4M | $137.2M |
| Total liabilities | $286.5M | $69.8M | $8.1M | $13.4M | $27.5M |
| Shareholders' equity | -$187.8M | -$21.4M | $37.9M | $76.0M | $109.7M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology